Rhode Island 2023 Regular Session

Rhode Island Senate Bill S1040

Introduced
5/19/23  

Caption

Procedure Generally -- Evidence

Impact

The removal of the collateral source rule could significantly affect personal injury litigation in Rhode Island. Proponents argue that it leads to fairer outcomes, ensuring that damages awarded to plaintiffs do not compensate them for amounts they did not actually incur out-of-pocket due to existing insurance. This, they claim, promotes greater accountability for medical practitioners while potentially reducing insurance costs for healthcare providers. However, opponents fear that this change jeopardizes the rights of injured patients and diminishes their financial recovery, undermining the intent of receiving compensation for real harm suffered.

Summary

Bill S1040 aims to repeal the collateral source rule in Rhode Island's medical malpractice actions. Currently, this rule prevents defendants in malpractice lawsuits from introducing evidence of benefits received by the plaintiff from other sources, such as health insurance or workers' compensation, in calculating damages. By allowing defendants to present this evidence, the bill seeks to alter the landscape of personal injury cases involving medical professionals, scaling back the amount awarded to plaintiffs based on 'double-dipping' into insurance benefits.

Contention

Discussions around S1040 have highlighted a polarizing divide on medical malpractice law reform. Advocates contend that the discussions surrounding the bill center on transparency and fairness, while detractors warn it could discourage patients from seeking necessary care or filing legitimate claims due to perceived bias in injury compensation. Concerns regarding access to justice for plaintiffs are also prominent, sparking debates over whether the intended benefits of cost savings for the healthcare system outweigh the potential risks to patient rights and access to justice.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.